Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APHA NYSE:BHC NASDAQ:CARA NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ABHCBausch Health Cos$5.71-3.1%$5.98$4.25▼$9.85$2.18B0.411.39 million shs1.34 million shsCARACara Therapeutics$15.19$8.13▼$19.08$24.33M0.4122,224 shs237,144 shsPBHPrestige Consumer Healthcare$73.73-0.3%$80.65$64.94▼$90.04$3.65B0.43406,596 shs423,917 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos-2.97%-15.59%-19.69%+5.45%-5.31%CARACara Therapeutics0.00%0.00%0.00%0.00%+27.36%PBHPrestige Consumer Healthcare-0.26%-3.96%-8.00%-12.47%+4.12%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPHAAphriaN/AN/AN/AN/AN/AN/AN/AN/ABHCBausch Health Cos4.5519 of 5 stars2.94.00.04.02.23.31.9CARACara Therapeutics0.2378 of 5 stars0.00.00.04.20.00.80.0PBHPrestige Consumer Healthcare4.3423 of 5 stars3.32.00.03.53.61.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/ABHCBausch Health Cos 2.00Hold$9.0057.62% UpsideCARACara Therapeutics 0.00N/AN/AN/APBHPrestige Consumer Healthcare 2.50Moderate Buy$93.3326.59% UpsideCurrent Analyst Ratings BreakdownLatest CARA, APHA, PBH, and BHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025PBHPrestige Consumer HealthcareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/2/2025BHCBausch Health CosRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$8.50 ➝ $10.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphria$405.96M12.00$0.09 per share166.43$4.80 per share3.20BHCBausch Health Cos$9.63B0.22$7.51 per share0.76($0.89) per share-6.42CARACara Therapeutics$7.14M0.00N/AN/A$12.58 per share0.00PBHPrestige Consumer Healthcare$1.14B3.20$5.20 per share14.18$37.04 per share1.99Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphria-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/ABHCBausch Health Cos-$46M$0.2621.961.23N/A0.99%-522.39%5.28%N/ACARACara Therapeutics-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/APBHPrestige Consumer Healthcare$214.60M$4.2917.1915.492.2218.86%12.87%6.78%8/7/2025 (Estimated)Latest CARA, APHA, PBH, and BHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q1 2026PBHPrestige Consumer Healthcare$1.01N/AN/AN/A$260.71 millionN/A7/30/2025Q2 2025BHCBausch Health Cos$0.97$0.90-$0.07$0.40$2.47 billion$2.57 billion5/8/2025Q4 2025PBHPrestige Consumer Healthcare$1.30$1.32+$0.02$1.00$289.36 million$296.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/ABHCBausch Health CosN/AN/AN/AN/AN/ACARACara TherapeuticsN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria0.252.361.17BHCBausch Health CosN/A1.350.97CARACara TherapeuticsN/A4.774.71PBHPrestige Consumer Healthcare0.554.202.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphria10.30%BHCBausch Health Cos78.65%CARACara Therapeutics44.66%PBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/ABHCBausch Health Cos8.05%CARACara Therapeutics3.10%PBHPrestige Consumer Healthcare1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/AOptionableBHCBausch Health Cos20,700370.09 million340.29 millionOptionableCARACara Therapeutics804.57 million4.43 millionOptionablePBHPrestige Consumer Healthcare54049.42 million48.72 millionOptionableCARA, APHA, PBH, and BHC HeadlinesRecent News About These CompaniesPrestige Consumer Healthcare (PBH) Projected to Post Quarterly Earnings on ThursdayAugust 1 at 5:44 AM | marketbeat.comXTX Topco Ltd Purchases 17,761 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 31 at 3:22 AM | marketbeat.comNorth Star Asset Management Inc. Trims Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 30 at 3:44 AM | marketbeat.comPacific Capital Partners Ltd Buys New Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 30 at 3:43 AM | marketbeat.comNorden Group LLC Sells 5,210 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 29, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Trims Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 29, 2025 | marketbeat.comChoreo LLC Sells 3,627 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 27, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of "Moderate Buy" by AnalystsJuly 22, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital AgeJuly 21, 2025 | insidermonkey.comJennison Associates LLC Sells 41,798 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 21, 2025 | marketbeat.comVictory Capital Management Inc. Reduces Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 18, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Stake Lowered by Massachusetts Financial Services Co. MAJuly 18, 2025 | marketbeat.comEnvestnet Asset Management Inc. Purchases 10,876 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 18, 2025 | marketbeat.comWhat is Zacks Research's Forecast for PBH FY2026 Earnings?July 17, 2025 | marketbeat.comBank of New York Mellon Corp Sells 12,337 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 16, 2025 | marketbeat.comPrestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings ResultsJuly 15, 2025 | finance.yahoo.comPrestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings ResultsJuly 15, 2025 | globenewswire.comRice Hall James & Associates LLC Has $46.87 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 14, 2025 | marketbeat.comConcurrent Investment Advisors LLC Acquires Shares of 4,203 Prestige Consumer Healthcare Inc. (NYSE:PBH)July 12, 2025 | marketbeat.comPrincipal Financial Group Inc. Acquires 8,291 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 10, 2025 | marketbeat.comEULAV Asset Management Invests $1.67 Million in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 7, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCARA, APHA, PBH, and BHC Company DescriptionsAphria NASDAQ:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Bausch Health Cos NYSE:BHC$5.71 -0.18 (-3.06%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$5.65 -0.06 (-1.05%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Cara Therapeutics NASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.Prestige Consumer Healthcare NYSE:PBH$73.73 -0.22 (-0.30%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$73.68 -0.05 (-0.07%) As of 08/1/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
